SESN1 Antibody Blocking Peptide

Novus Biologicals | Catalog # NBP1-44993PEP

Novus Biologicals
Loading...

Key Product Details

Source

Synthetic

Applications

Antibody Competition
Loading...

Product Specifications

Description

Synthetic peptide taken within amino acid region 1-50 on human SESN1 protein.

Accession #: Q9Y6P5

Source: Synthetic

Purity

>85%, by HPLC

Application Notes

This peptide is useful as a blocking peptide for NBP1-44993.

For further blocking peptide related protocol, click here.

Protein / Peptide Type

Antibody Blocking Peptide

Scientific Data Images for SESN1 Antibody Blocking Peptide

Western Blot: SESN1 Antibody Blocking Peptide [NBP1-44993PEP]

Western Blot: SESN1 Antibody Blocking Peptide [NBP1-44993PEP]

Western Blot: SESN1 Blocking Peptide [NBP1-44993PEP] - Western Blot of SESN1 Blocking Peptide with SESN1 Antibody in DiluObuffer.

Formulation, Preparation, and Storage

NBP1-44993PEP
Formulation Sodium Bicarbonate buffer, pH 8.00 containing up to 10% DMSO
Concentration 2.5 mg/ml
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -20C. Avoid freeze-thaw cycles.

Background: SESN1

Sestrin 1(SESN1), located on rat chromosome 20q13, belongs to the sestrin family of proteins. These proteins are cystein sulfinyl reductases and they modulate peroxide signaling and antioxidant defense (1). This family of proteins is only present in multicellular organisms ranging from nematodes to mammals. These proteins selectively reduce or repair hyperoxidized forms of typical 2-Cys peroxiredoxins within eukaryotes (2). Peroxiredoxins are the enzymes that metabolize peroxides. Expression of these proteins is regulated by p53, a tumor suppressor protein (3). Sestrin 1 is implicated in the inhibition of cell growth. It has been reported that Sestrin 1 activates AMP-responsive protein kinase (AMPK) and targets it to phosphorylate TSC2, a tumor suppressor. Phosphorylation of TSC2 stimulates its GAP activity which inhibits the activity of mTOR, a positive regulator of cell growth, thus leading to inhibition of cell proliferation and growth (4). Inhibition of mRNAs from sestrin 1 and 3 genes has been shown to substantially increase intracellular ROS levels. This increase in ROS is linked to Ras-induced mutagenesis which is one of the most common events in cancer (5). Sestrin 1 was also identified as a candidate gene for heterotaxia in humans (6). Recent studies have identified that AMPK is an essential mediator of tumor suppressor LKB1 and is suppressed in cancer cells (7). Since activity of AMPK is regulated by sestrin 1, this protein could be a promising target for cancer treatment and therapy. Sestrin 1 is approximately a 66.1kDa protein in humans (551 amino acids) and 55.4kDa protein in mouse and rat (462 amino acids).

Alternate Names

MGC138241, MGC142129, p53-regulated protein PA26, PA26p53 activated gene 26, SEST1p53 regulated PA26 nuclear protein, sestrin 1, sestrin-1

Gene Symbol

SESN1

Additional SESN1 Products

Product Documents for SESN1 Antibody Blocking Peptide

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Product Specific Notices for SESN1 Antibody Blocking Peptide

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Customer Reviews for SESN1 Antibody Blocking Peptide

There are currently no reviews for this product. Be the first to review SESN1 Antibody Blocking Peptide and earn rewards!

Have you used SESN1 Antibody Blocking Peptide?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for SESN1 Antibody Blocking Peptide (NBP1-44993PEP):

Antibody Competition Protocol for SESN1 Protein (NBP1-44993PEP):
In this assay the antigen binding sites (Fab) of a particular antibody is allowed to bind to homologous antigenic peptide in several hundred molar excess ratio of immunoglobulin to peptide. Since the antigenic peptide has higher affinity for Fab site than the full length native proteins, the antigen binding site is blocked thus antibodies are unable to bind to the specific sites on either native, partial denatured or completely denature antigen on sections, in solution or on membrane blots.

Before starting, standardize the conditions for Western blot, immunoprecipitation or immunohistochemistry using the relevant antibody. Conditions include: volume of antibody used; dilution factor, final volume, incubation time, washing conditions etc.Once conditions have been standardized, repeat the same protocol in duplicate using blocked and unblocked antibody.

Begin the competition assay by preparing the blocked antibody-peptide solution:

1. Take the same volume of antibody as previously standardized. Let us assume 10 uL in 15 mL.
2. Add approximately 1:200 moles of excess peptide (peptides are generally 2200 dalton). This will be equivalent of approximately 60-70ul of peptide solution (original peptide concentration is 2.5mg/ml).
3. Mix 10 uL of antibody with 60-70 uL of peptide and make up the volume to 200 uL using DiluOBuffer.

Compare the above blocked antibody-peptide solution with control antibody:

1. Take same amount of antibody as used in the blocked antibody-peptide solution and add 60-70 ul of PBS and make up the volume to 200 ul using DiluOBuffer.
2. Once both blocked antibody-peptide solution and the control antibody solution have been made, incubate both solutions at 4 degrees C overnight on a rotating mixer. Centrifuge both tubes at 12,000-14000 xg for 1-2 minute at 4 degrees C. A small amount of precipitate may accumulate in the blocked antibody-peptide solution due to antibody-antigen complex formation. If this occurs, carefully remove the precipitate and use only the supernatant.
3. Dilute both solutions in 1X DiluOBuffer to the final dilution volume of 15 mL. The antibody-peptide solution will not give any labeling or will have significantly reduced labeling while the Control Antibody solution should provide standard results.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes
Loading...